| Halley Crissman, MD | |
|
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
| (734) 936-4000 | |
| Not Available |
| Full Name | Halley Crissman |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 9 Years |
| Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750763371 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 4301117079 (Michigan) | Secondary |
| 207VC0300X | Obstetrics & Gynecology - Complex Family Planning | 4301117079 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of Michigan | 3779496856 | 2953 |
News Archive
One of the most ambitious programmes to provide lasting improvements in nutrition in sub-Saharan Africa begins today when a diverse multinational team of experts from agriculture to ethics start looking for ways to end dietary deficiencies in essential micronutrients.
BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.
Biomedical Engineering's Matthew Smith and Byron Yu, along with former Ph.D. student Ben Cowley (School of Computer Science '18), have studied the neural basis through which internal states in the brain affect decision-making over an extended period of time.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.
In this Lancet opinion piece, Ruchama Marton, president and founder of Physicians for Human Rights – Israel writes, "Everything one can say about the health-care system in Palestine was summed up by the physician and political leader Haidar Abdel-Shafi … in September, 1993. He said: 'We cannot take care of health and education as long as we live under occupation.'"
› Verified 9 days ago
| Entity Name | Regents Of The University Of Michigan |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942235163 PECOS PAC ID: 3779496856 Enrollment ID: O20031117000778 |
News Archive
One of the most ambitious programmes to provide lasting improvements in nutrition in sub-Saharan Africa begins today when a diverse multinational team of experts from agriculture to ethics start looking for ways to end dietary deficiencies in essential micronutrients.
BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.
Biomedical Engineering's Matthew Smith and Byron Yu, along with former Ph.D. student Ben Cowley (School of Computer Science '18), have studied the neural basis through which internal states in the brain affect decision-making over an extended period of time.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.
In this Lancet opinion piece, Ruchama Marton, president and founder of Physicians for Human Rights – Israel writes, "Everything one can say about the health-care system in Palestine was summed up by the physician and political leader Haidar Abdel-Shafi … in September, 1993. He said: 'We cannot take care of health and education as long as we live under occupation.'"
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Halley Crissman, MD 3621 S State St, Ann Arbor, MI 48108-1633 Ph: (734) 647-5299 | Halley Crissman, MD 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 936-4000 |
News Archive
One of the most ambitious programmes to provide lasting improvements in nutrition in sub-Saharan Africa begins today when a diverse multinational team of experts from agriculture to ethics start looking for ways to end dietary deficiencies in essential micronutrients.
BELLUS Health Inc. and Celtic Therapeutics announced today that a global confirmatory phase III clinical study was initiated on December 14, 2010 for KIACTA™ (eprodisate). KIACTA™ is a drug candidate being developed for the treatment of AA amyloidosis, a life-threatening orphan disease that occurs in patients with long-lasting inflammatory conditions, most commonly due to rheumatoid arthritis. The study is designed to confirm the safety and efficacy of KIACTA™ in preventing renal function decline in patients with AA amyloidosis.
Biomedical Engineering's Matthew Smith and Byron Yu, along with former Ph.D. student Ben Cowley (School of Computer Science '18), have studied the neural basis through which internal states in the brain affect decision-making over an extended period of time.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces it has signed a non-exclusive license agreement with BioWa Inc., the exclusive worldwide licensor of POTELLIGENT Technology.
In this Lancet opinion piece, Ruchama Marton, president and founder of Physicians for Human Rights – Israel writes, "Everything one can say about the health-care system in Palestine was summed up by the physician and political leader Haidar Abdel-Shafi … in September, 1993. He said: 'We cannot take care of health and education as long as we live under occupation.'"
› Verified 9 days ago
Evangelia Lea Lazaris, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Olivia Winfrey, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Dr. Ellery Grace Sarosi, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 | |
Joanne Vicari Block, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4350 Jackson Rd Ste 300, Ann Arbor, MI 48103 Phone: 734-995-2259 Fax: 734-995-2418 | |
Aisha Yousuf, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Drive, L4100 Womens, Ann Arbor, MI 48109 Phone: 734-936-9434 Fax: 734-647-1006 | |
Dr. Edwin Peter Peterson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 375 W Northfield Church Rd, Ann Arbor, MI 48105 Phone: 734-663-1705 Fax: 734-663-1302 | |
Dr. Ashley Mia Dowgiert, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4350 Jackson Rd, Suite 300, Ann Arbor, MI 48103 Phone: 734-995-2259 Fax: 734-995-2418 |